A prospective real-world analysis of erenumab in refractory chronic migraine
Giorgio Lambru, Bethany Hill, Madeleine Murphy, Ivona Tylova, Anna P. Andreou
Journal
- ISSN / E-ISSN
- — / —
- DOI
- 10.1186/s10194-020-01127-0 ↗
- Volume · Issue · Pages
- 21 · 1 · 61-61
- Publisher
- Springer-Verlag Italia Srl
- Article URL
- https://doi.org/10.1186/s10194-020-01127-0 ↗
- Article details
- Unverified
Publication date (each date has its type and source)
01 Jun 2020
OpenAlex publication date · source: OpenAlex
| Type | Date | Source |
|---|---|---|
| OpenAlex publication date | 01 Jun 2020 | OpenAlex |
Keywords (as given): erenumab; chronic migraine; refractory migraine; migraine prophylaxis; calcitonin gene-related peptide; medication overuse headache; migraine days; headache-related disability; treatment tolerability; real-world effectiveness; HIT-6; adverse events
HEC Status at Publication Not the journal's current status
HEC Status at PublicationNot conclusive
Historical status could not be conclusively determined.
- HEC status cannot be determined for this date: no HEC list is recorded as in effect on it.
Best available information, not a definitive status: HEC status cannot be determined for this date: no HEC list is recorded as in effect on it.
- Journal
- Journal of Headache and Pain
- Publication date used
- 01 Jun 2020 (OpenAlex publication date)
- Applicable HEC period
- None recorded for this date
- Category
- —
- Recognition status
- Unknown (NO_PERIOD_FOR_DATE)
- Source
- —
- Verification status
- Not available
This is an automatically generated summary based on the information available on the publication date. Terms & conditions apply.